Introduction to Fairness Opinions In the complex world of corporate transactions, fairness opinions serve as an essential tool to ensure that all parties involved receive ...
The biotech and life sciences industry is experiencing a continuing rebound in 2024. After an overall market slowdown in investments and acquisitions, late Q4 2023 ...
Your pharmaceutical services company will likely attract significant attention from acquisition firms and larger pharma companies trying to expand their markets, customers, technology, and products. ...
In this Contract Research Organization (CRO) M&A Industry Update, we explore the M&A activity and projections for this sector within the Business Services industry. Within this ...
In this CRO Report, we provide tailwinds driving growth in the industry, an industry analysis, public comparables and precedent transactions, active buyers in the market, ...
Managing Director and regular PharmaBoardroom contributor David H. Crean. Ph.D looks at how the ongoing global coronavirus (COVID-19) outbreak has impacted the global economy, ...
The healthcare and life sciences tech industry has experienced some geopolitical uncertainties and market volatility in recent years. But, despite these challenges, there is still ...
Within the women’s healthcare industry, mergers & acquisitions (M&A) activity over the last couple of years has been prevalent and increasing within the fertility service ...
Healthcare and Life Science Sector Trends Cautiously optimistic. That is the tone for the Healthcare and Life Sciences Sector as we head into 2019. Many ...
Join CohnReznick, Objective Capital Partners, Wilson Sonsini and an Exclusive Group of Life Science Executives for Engaging Discussion on May 17 San Diego, CA- April 18, ...
